You are here: Welcome to the MPKB » Welcome to the MPKB » Resources for physicians » Physicians' concerns about the Marshall Protocol
Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
Next revisionBoth sides next revision
home:physicians:concerns [07.10.2019] – [Concerns about lack of clinical evidence] sallieqhome:physicians:concerns [07.13.2019] – [Concerns about immunopathology] sallieq
Line 27: Line 27:
 <html></p></div></html> <html></p></div></html>
  
-===== Recorded results assessed 2013  =====+==== Recorded results assessed 2013  ====
  
 <blockquote>//DJ posted// :- During the summer of 2013 I looked at 2,000 records of people using the Marshall Protocol.</blockquote>  <blockquote>//DJ posted// :- During the summer of 2013 I looked at 2,000 records of people using the Marshall Protocol.</blockquote> 
Line 81: Line 81:
  
   - **"A temporary increase in symptoms or laboratory values means the treatment is not working."** – \\ Immunopathology is an increase in one's present symptoms of Th1 inflammation or a return of previous Th1 inflammatory symptoms, that is caused by cytokines and endotoxins being released from dying bacteria. In some cases there may be a temporary experience of symptoms attributable to a previously unexperienced condition. Immunopathology is a necessary part of recovery. The amount of immunopathology a patient experiences on the Marshall Protocol (MP) is correlated with disease severity. Patients who are less sick will have comparatively less strong immunopathology. [[home:protocol:immunopathology|Read more →]]   - **"A temporary increase in symptoms or laboratory values means the treatment is not working."** – \\ Immunopathology is an increase in one's present symptoms of Th1 inflammation or a return of previous Th1 inflammatory symptoms, that is caused by cytokines and endotoxins being released from dying bacteria. In some cases there may be a temporary experience of symptoms attributable to a previously unexperienced condition. Immunopathology is a necessary part of recovery. The amount of immunopathology a patient experiences on the Marshall Protocol (MP) is correlated with disease severity. Patients who are less sick will have comparatively less strong immunopathology. [[home:protocol:immunopathology|Read more →]]
 +
 +see also [[home:protocol:olmesartan:safety|https://mpkb.org/home/protocol/olmesartan/safety#recent_research|research into enteropathy]] 
  
 ===== Concerns about antibiotics=====  ===== Concerns about antibiotics===== 
home/physicians/concerns.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.